---
figid: PMC6676344__fphar-10-00820-g002
figtitle: Graphical summary of the anticancer mechanisms of formononetin
organisms:
- Agaricus bisporus
- Medicago sativa
- Cicer arietinum
- Astragalus membranaceus
- Trifolium pratense
- Glycyrrhiza glabra
- Sophora flavescens
- Astragalus mongholicus
- Bipolaris zeicola
- Trifolium subterraneum
- Amorpha fruticosa
- Ononis spinosa
- Actaea racemosa
- Cananga odorata
- Pterocarpus indicus
- Baptisia australis
- Dalbergia stevensonii
- Dalbergia ecastaphyllum
- Phyllolobium chinense
- Andira inermis
- Bolusanthus speciosus
- Glycyrrhiza pallidiflora
- Euphorbia portlandica
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Bos taurus
- unidentified
pmcid: PMC6676344
filename: fphar-10-00820-g002.jpg
figlink: /pmc/articles/PMC6676344/figure/f2/
number: F2
caption: Graphical summary of the anticancer mechanisms of formononetin. Formononetin
  acts on multiple signaling pathways in cancer cells. It induces apoptosis via classical
  caspase-dependent pathway and modulation of Bcl-2 family of proteins. It induces
  cell cycle arrest by modulating the cycle regulatory proteins. It inactivates signaling
  pathways, namely, JAK/STAT pathway, PI3K/AKT pathway, as well as MAPK (ERK1/2) pathways.
  Formononetin also modulates several miRNA expressions as well as supresses cell
  migration, invasion, and angiogenesis (; ; ; ; ; ; ; ; ; ; ). NAG-1, nonsteroidal
  anti-inflammatory drug (NSAID)-activated gene-1; IAP, inhibitors of apoptosis proteins;
  IL-6, interleukin-6; PARP, poly(ADP-ribose) polymerase; GSH, glutathione; GSSG,
  oxidized glutathione; GR, glutathione reductase; PTEN, phosphatase and tensin; HIFα,
  hypoxia inducible factor α; miR, microRNA; TIMP, tissue inhibitors of metalloproteinases;
  ER, estrogen receptor; MMP, matrix metalloproteinases; CDK, cyclin dependent kinases;
  STAT, signal transducer and activator of transcription; PI3K, phosphatidylinositol
  3-kinase; AKT, protein kinase B; VEGF, vascular endothelial growth factor; FGF,
  fibroblast growth factor; FGFR, fibroblast growth factor receptor; IGF-1R, insulin-like
  growth factor 1 receptor; ERK, extracellular signal-regulated kinase; JAK, Janus
  kinase; ROS, reactive oxygen species.
papertitle: 'Formononetin: A Review of Its Anticancer Potentials and Mechanisms.'
reftext: Kai-Ching Tay, et al. Front Pharmacol. 2019;10:820.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9697398
figid_alias: PMC6676344__F2
figtype: Figure
organisms_ner:
- Rattus norvegicus
- Bos taurus
- Homo sapiens
- Mus musculus
redirect_from: /figures/PMC6676344__F2
ndex: a31226db-dec9-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6676344__fphar-10-00820-g002.html
  '@type': Dataset
  description: Graphical summary of the anticancer mechanisms of formononetin. Formononetin
    acts on multiple signaling pathways in cancer cells. It induces apoptosis via
    classical caspase-dependent pathway and modulation of Bcl-2 family of proteins.
    It induces cell cycle arrest by modulating the cycle regulatory proteins. It inactivates
    signaling pathways, namely, JAK/STAT pathway, PI3K/AKT pathway, as well as MAPK
    (ERK1/2) pathways. Formononetin also modulates several miRNA expressions as well
    as supresses cell migration, invasion, and angiogenesis (; ; ; ; ; ; ; ; ; ; ).
    NAG-1, nonsteroidal anti-inflammatory drug (NSAID)-activated gene-1; IAP, inhibitors
    of apoptosis proteins; IL-6, interleukin-6; PARP, poly(ADP-ribose) polymerase;
    GSH, glutathione; GSSG, oxidized glutathione; GR, glutathione reductase; PTEN,
    phosphatase and tensin; HIFα, hypoxia inducible factor α; miR, microRNA; TIMP,
    tissue inhibitors of metalloproteinases; ER, estrogen receptor; MMP, matrix metalloproteinases;
    CDK, cyclin dependent kinases; STAT, signal transducer and activator of transcription;
    PI3K, phosphatidylinositol 3-kinase; AKT, protein kinase B; VEGF, vascular endothelial
    growth factor; FGF, fibroblast growth factor; FGFR, fibroblast growth factor receptor;
    IGF-1R, insulin-like growth factor 1 receptor; ERK, extracellular signal-regulated
    kinase; JAK, Janus kinase; ROS, reactive oxygen species.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Il6
  - Vegfa
  - Fgf2
  - Igf1r
  - Fgfr2
  - Timp1
  - Timp2
  - Src
  - Pik3cg
  - Mapk3
  - Mapk1
  - Stat5a
  - Stat3
  - Mmp9
  - Mmp2
  - Pten
  - Mapk14
  - Akt1
  - Esr2
  - Mir21
  - Bcl2
  - Bcl2l1
  - Bax
  - Mir375
  - Mir149
  - Cdk2
  - Ccne1
  - Esr1
  - Cdk4
  - Defb1
  - Kras
  - Ccnd1
  - Akp3
  - Ephb3
  - Mapk10
  - Erg
  - Mpeg1
  - Fabp4
  - Tap2
  - Tap1
  - IL6
  - VEGFA
  - FGF2
  - IGF1R
  - FGFR2
  - TIMP2
  - TIMP1
  - SRC
  - PIK3CB
  - MAPK3
  - MAPK1
  - STAT3
  - MMP9
  - MMP2
  - ALPI
  - CD47
  - PTEN
  - MAPK14
  - AKT1
  - ESR2
  - MIR21
  - BCL2
  - BCL2L1
  - BAX
  - MIR375
  - MIR149
  - CDK2
  - CDK4
  - CDKN1A
  - CCND1
  - EPHB3
  - ERG
  - MPEG1
  - TAP2
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - FGF13
  - PARP1
  - COL11A2
  - PARP2
  - PARP3
  - PARP4
  - PARP6
  - PARP8
  - PARP9
  - PARP10
  - PARP11
  - PARP12
  - PARP14
  - PARP15
  - PARP16
  - TNKS
  - TNKS2
  - TIPARP
  - FGR
  - FYN
  - YES1
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - PIK3CA
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - STAT5A
  - STAT5B
  - GDF15
  - ALPP
  - IAPP
  - MAGT1
  - CRK
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - RPS6KA1
  - RPS6KA2
  - RPS6KA3
  - RPS6KA4
  - RPS6KA5
  - RPS6KA6
  - AKT2
  - AKT3
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - ATP8A2
  - CDKL1
  - CDKL2
  - CDKL3
  - CDKL4
  - CDKL5
  - CDK3
  - CDK5
  - CDK6
  - CDK7
  - CDK8
  - CDK9
  - CDK10
  - CDK11A
  - CDK11B
  - CDK12
  - CDK13
  - CDK14
  - CDK15
  - CDK16
  - CDK17
  - CDK18
  - CDK19
  - CDK20
  - CDK1
  - CCNA1
  - CCNA2
  - ESR1
  - ERAL1
  - CCNE1
  - CCNE2
  - TCEAL1
  - NSG1
  - H3P16
  - HIF1A
  - EPAS1
  - HIF3A
  - MAP2K4
  - FABP4
  - GTF3A
  - TFAP2A
  - TERT
  - TNP2
  - SEC14L3
  - Parp1
  - Pik3r1
  - Casp3
  - Gdf15
  - Casp9
  - Iap1-3
  - Cd47
  - Magt1
  - Crk
  - Grap2
  - Syp
  - Ahsa1
  - Rps6ka1
  - Rps6ka2
  - Mir21a
  - Nkx3-1
  - Cdkn1a
  - Nsg1
  - Tpt1
  - Tceal1
  - Iap2
  - Birc3
  - Birc2
  - pk
  - Map2k4
  - Tyrosine
  - GSH
  - GSSG
  - ATP
  - Cancer
---
